Business and Professions Code section 22949.51

For purposes of this chapter, the following definitions apply:

(a)

“Gene therapy” refers to the administration of genetic material to modify or manipulate the expression of a gene product, or to alter the biological properties of living cells, for therapeutic use.

(b)

“Gene therapy kit” refers to a product that is sold as a collection of materials for the purpose of facilitating gene therapy experiments, including, but not limited to, a system for the targeted cutting of DNA molecules, such as type II clustered regularly interspaced short palindromic repeats (CRISPR), associated proteins (CRISPR-Cas) systems, including CRISPR-Cas9, as described in Regents of University of California v. Broad Institute, Inc. (2018) 903 F.3d 1286.

Source: Section 22949.51, https://leginfo.­legislature.­ca.­gov/faces/codes_displaySection.­xhtml?lawCode=BPC§ionNum=22949.­51.­ (updated Jan. 1, 2020; accessed Dec. 29, 2025).

Green check means up to date. Up to date

Verified:
Dec. 29, 2025

§ 22949.51's source at ca​.gov